COVID-19 Vaccine Messaging, Part 1
- Conditions
- COVID-19Vaccination
- Interventions
- Other: Control messageOther: Baseline messageOther: Personal freedom messageOther: Community interest messageOther: Anger messageOther: Self-interest messageOther: Economic benefit messageOther: Guilt messageOther: Embarrassment messageOther: Economic freedom messageOther: Trust in science messageOther: Not bravery message
- Registration Number
- NCT04460703
- Lead Sponsor
- Yale University
- Brief Summary
This study tests different messages about vaccinating against COVID-19 once the vaccine becomes available. Participants are randomized to 1 of 12 arms, with one control arm and one baseline arm. We will compare the reported willingness to get a COVID-19 vaccine at 3 and 6 months of it becoming available between the 10 intervention arms to the 2 control arms.
Study participants are recruited online by Lucid, which matches census based sampling in online recruitment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4000
- At least 18 years of age
- US resident
- Younger than 18 years of age
- Non-US resident
- Do not consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Control message Control message about birdfeeding Baseline message Baseline message These participants will be assigned a message about the benefits of vaccination. All other treatment arms include this baseline language. Personal freedom Personal freedom message Experimental message arm. Social benefit, community interest Community interest message Experimental message arm. Social pressure- anger Anger message Experimental message arm. Social benefit, self-interest Self-interest message Experimental message arm. Economic benefit Economic benefit message Experimental message arm. Social pressure- guilt Guilt message Experimental message arm. Social pressure- embarrassment Embarrassment message Experimental message arm. Economic freedom Economic freedom message Experimental message arm. Trust in science Trust in science message Experimental message arm. Not bravery arm Not bravery message Experimental message arm.
- Primary Outcome Measures
Name Time Method Intention to get COVID-19 vaccine Immediately after intervention, in the same survey in which the intervention message is provided This is a self reported measure, immediately after the intervention message, of the likelihood of getting a COVID-19 vaccination within 3 months and then 6 months of it becoming available. During analysis, responses among those assigned to different intervention messages will be compared to those in the control group.
- Secondary Outcome Measures
Name Time Method Persuade others item Immediately after intervention, in the same survey in which the intervention message is provided This is a measure of a willingness to persuade others to take the COVID-19 vaccine.
Fear of those who have not been vaccinated Immediately after intervention, in the same survey in which the intervention message is provided This is a measure of a comfort with an unvaccinated individual visiting an elderly friend after a vaccine becomes available
Vaccine confidence scale Immediately after intervention, in the same survey in which the intervention message is provided This is a validated scale. This scale will be used to assess the impact of the messages on vaccine confidence. (Outcome assessed only for the half of the sample that answers these items post-treatment)
Social judgment of those who do not vaccinate Immediately after intervention, in the same survey in which the intervention message is provided This is a scale composed of 4 items measuring the trustworthiness, selfishness, likeableness, and competence of those who choose not to get vaccinated after a vaccine becomes available
Trial Locations
- Locations (1)
Yale University
πΊπΈNew Haven, Connecticut, United States